ストックスクリーナーアプリを入手
0.2551
5.85%
0.0141
プレマーケット:
.25
-0.0051
-2.00%
Theriva Biologics Inc (TOVX) 最新ニュース
CEO Moves: Is Theriva Biologics Inc subject to activist investor interest2026 Momentum Check & Free High Return Stock Watch Alerts - baoquankhu1.vn
TOVX Should I Buy - Intellectia AI
Theriva Biologics to reschedule stockholder meeting after lack of quorum By Investing.com - Investing.com Australia
Theriva Biologics, Inc. (TOVX) Files Form 8-K with SEC – Company Details and Exchange Information as of April 2026 - Minichart
Theriva Biologics to reschedule stockholder meeting after lack of quorum - Investing.com
Resistance Check: Is Theriva Biologics Inc in a long term uptrend2026 Rallies & Stock Market Timing Techniques - baoquankhu1.vn
Theriva Biologics Faces Delays in Warrant Approval Meeting - TipRanks
Theriva Bi Called Special Meeting Fails to Reach Quorum; Will Re‑call Meeting to Seek Approval for 16.18M Warrant Shares - TradingView — Track All Markets
Theriva Biologics (NYSE American: TOVX) resets vote on 16,184,560 warrant shares - Stock Titan
Aug Opening: Is Theriva Biologics Inc backed by strong institutional buyingEarnings Overview Summary & Free Real-Time Volume Trigger Notifications - baoquankhu1.vn
Aug Gainers: Why is Theriva Biologics Inc stock going downStock Surge & Consistent Growth Stock Picks - baoquankhu1.vn
Aug Shorts: Does Theriva Biologics Inc have pricing power2026 Fed Impact & Verified Short-Term Plans - baoquankhu1.vn
TOVX Technical Analysis & Stock Price Forecast - Intellectia AI
TOVX Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Theriva Biologics (TOVX) Receives Upgrade from Maxim Group | TOV - GuruFocus
Theriva Biologics Raised to Buy From Hold by Maxim Group - Moomoo
Maxim Group Upgrades Theriva Biologics(TOVX.US) to Buy Rating, Raises Target Price to $1 - Moomoo
Analyst Calls: Is Theriva Biologics Inc showing insider buyingIPO Watch & Community Verified Swing Trade Signals - baoquankhu1.vn
Aug Intraday: Does Theriva Biologics Inc have pricing power2026 Institutional Moves & Daily Growth Stock Tips - baoquankhu1.vn
Portfolio Recap: Does Theriva Biologics Inc have strong EBITDA margins2026 Movers & Weekly Top Gainers Trade List - baoquankhu1.vn
Maxim Group Maintains Theriva Biologics(TOVX.US) With Hold Rating - Moomoo
Maxim Group Maintains Theriva Biologics(TOVX.US) With Hold Rating, Announces Target Price $0.22 - Moomoo
Theriva Biologics Receives FDA Agreement to Advance VCN-01 to Phase 3 Trial for Metastatic Pancreatic Cancer 1 - Minichart
Theriva Biologics announces outcome of Type B End-of-Phase 2 meeting with FDA - TipRanks
Theriva Biologics Announces Positive End-Of-Phase 2 Meeting With U.S. FDA Regarding The Design Of A Phase 3 Trial Of VCN-01 In Metastatic Pancreatic Ductal Adenocarcinoma - MarketScreener
Theriva™ Biologics reports full-year 2025 operational highlights and financial results - MSN
Theriva™ Biologics Reports Full-Year 2025 Operational Highlights and Financial Results - Stocktwits
Theriva Biologics (TOVX) Advances Phase 3 Clinical Trial Plans f - GuruFocus
Theriva Biologics Advances VCN-01 Into Pivotal Phase 3 - TipRanks
Theriva gets FDA alignment on phase 3 trial design for VCN-01 - Investing.com Canada
Theriva Biologics aligns with FDA on Phase 3 VCN-01 design for metastatic PDAC - TradingView
Theriva Biologics (NYSE: TOVX) gains FDA alignment on pivotal VCN-01 Phase 3 in metastatic PDAC - Stock Titan
Theriva™ Biologics Announces Positive End-of-Phase 2 - GlobeNewswire
Theriva pushes pancreatic cancer drug VCN-01 toward Phase 3 - Stock Titan
If You Invested $1,000 in THERIVA BIOLOGICS INC (TOVX) - Stock Titan
Theriva Biologics (TOVX) Registration Filing Summary - Quartr
Chart Watch: Is Theriva Biologics Inc showing insider buying2026 Technicals & Target Return Focused Stock Picks - baoquankhu1.vn
TOVX Stock Price, Quote & Chart | THERIVA BIOLOGICS INC (NYSEARCA:TOVX) - ChartMill
Aug Swings: Will Theriva Biologics Inc outperform its industry peers2026 Key Lessons & Risk Managed Investment Signals - baoquankhu1.vn
Theriva Biologics (NYSE: TOVX) puts 16.2M warrant share issuance to vote - Stock Titan
Theriva Biologics, Inc. (TOVX) Stock Forecast & Price Prediction 2026–2030 - CoinCodex
Theriva Biologics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Theriva Biologics Reports Full-Year 2025 Operational Highlights and Financial Results - Bitget
TOVX Reports Strong Cash Position and Funding Plans for Clinical Trials - GuruFocus
Theriva 10-K: Net loss $23.74M, EPS $(2.08); Operating loss $24.05M - TradingView
Theriva Biologics reports $13.1M year-end cash, $25.2M net loss for 2025 - TradingView
Form 10-K Theriva Biologics, Inc. For: Dec 31 - StreetInsider
Theriva Biologics (NYSE: TOVX) details 2025 loss and cash runway into 2027 - Stock Titan
Cancer drug developer Theriva inks SYN-020 deal up to $38M - Stock Titan
Theriva Biologics, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
Aug Mood: Can Theriva Biologics Inc maintain sales growthStock Surge & Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Aug Shorts: Can Theriva Biologics Inc maintain sales growthAnalyst Upgrade & Step-by-Step Trade Execution Guides - baoquankhu1.vn
Theriva™ Biologics Announces Upcoming Presentation of Data from VCN-01 Retinoblastoma Phase 1 Clinical Trial at APAO 2026 - Stocktwits
Theriva Biologics (TOVX) asks shareholders to approve 16.18M warrant shares - Stock Titan
TOVX SEC FilingsTHERIVA BIOLOGICS INC 10-K, 10-Q, 8-K Forms - Stock Titan
Theriva™ Biologics Licenses SYN-020 to Rasayana Therapeutics for Multiple Indications - Stocktwits
TOVX Technical Analysis & ETF Price Forecast - Intellectia AI
Is Theriva Biologics Inc. stock a top pick in earnings season2025 Fundamental Recap & Intraday High Probability Setup Alerts - mfd.ru
TOVX Theriva Biologics AMEX pre-market +12% Feb 20 2026: Most active - Meyka
$30M Revenue Rocket, Super Spiders, and Biotech Patent Blitz Launch Morning Momentum - GlobeNewswire Inc.
Aug Update: What are Theriva Biologics Incs technical support levelsJuly 2025 News Drivers & Stepwise Trade Execution Plans - baoquankhu1.vn
2.69%
0.25%
大文字化:
|
ボリューム (24 時間):